- Corporate Officers - D
- Davis Thomas Andrew
Insider Trading History of Davis Thomas Andrew
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Davis Thomas Andrew since 2006.
This trader's CIK number is 1338185.
At the time of last reporting, Davis Thomas Andrew was the CHIEF MEDICAL OFFICER of Genocea Biosciences, Inc.. (stock ticker symbol GNCA).
Also see all insider trading activities at Genocea Biosciences, Inc..
Note that in the past
Davis Thomas Andrew also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Genocea Biosciences, Inc. (GNCA) by Davis Thomas Andrew
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2022 | GNCA | 0 | $0 | 3,808 | $4,351 | 0 | $0 |
Yearly summary of insider trading at Genvec Inc (GNVC) by Davis Thomas Andrew
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2005 | GNVC | 5,000 | $9,100 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Celldex Therapeutics, Inc. (CLDX) by Davis Thomas Andrew
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2010 | CLDX | 2,500 | $9,437 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Davis Thomas Andrew:
1. Genocea Biosciences, Inc. (GNCA)
2. Genvec Inc (GNVC)
3. Celldex Therapeutics, Inc. (CLDX)
Table 1. Insider trading of Genocea Biosciences, Inc. (GNCA) by Davis Thomas Andrew
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2022-04-04 | GNCA | Sale | 1,091 | 1.25 | 1,363 |
2022-03-16 | GNCA | Sale | 2,717 | 1.10 | 2,988 |
Table 2. Insider trading of Genvec Inc (GNVC) by Davis Thomas Andrew
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2005-11-22 | GNVC | Buy | 5,000 | 1.82 | 9,100 |
Table 3. Insider trading of Celldex Therapeutics, Inc. (CLDX) by Davis Thomas Andrew
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2010-09-16 | CLDX | Buy | 2,500 | 3.77 | 9,437 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Davis Thomas Andrew
(CHIEF MEDICAL OFFICER of Genocea Biosciences, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.